Arm's officers sold $62 million of stock as a judge weighs five years of Qualcomm royalties

A lobbying filing on the Qualcomm battlefield

Arm▼−2.96% — Arm, down 2.96 percent today Holdings, the Cambridge chip designer behind the processors in most phones, disclosed $130,000 of third-quarter lobbying on October 20↗ ¹. The filing lists export controls, the Chip Security Act (H.R.3447/S.1705) and "legislation focused on semiconductor design intellectual property" ¹. That is the ground of Arm's Delaware fight with Qualcomm, the phone-chip maker that licenses Arm's designs and pays royalties on them ².

On October 13, after a five-day trial, a jury found Arm breached its obligation to supply Qualcomm with software patches and tools↗, and intentionally interfered with Qualcomm's▲+1.64% — Qualcomm, up 1.64 percent today relations with Meta▼−2.28% — Meta, down 2.28 percent today Platforms ². Damages were $2 ². US District Judge Maryellen Noreika must still decide whether the breach lets Qualcomm stop paying royalties for five years, potentially worth billions, under a clause Arm argues is unenforceable ^{2 3}.

The royalty line behind the $300 billion pitch

Royalties brought Arm $715 million of its $1.29 billion in fiscal first-quarter revenue, up 22% on the year ³. The AGI CPU, Arm's first server-grade silicon, launched on March 24 with Meta as lead partner, and chief executive Rene Haas said on July 29 that demand "now exceeds $2 billion" ³.

At the Open Compute Project Global Summit, an industry conference, Arm pitched a CPU market rising from $52 billion this year to $300 billion by 2030 and showed partner racks holding up to 336 CPUs ⁴. Those rack benchmarks are modeled rather than measured ⁵.

What the Form 4s say, and what they leave out

Quiver Quantitative's six-month table, built from the Form 4 disclosures that every insider trade requires↗, counts 29 sales and no purchases ¹. Chief legal officer Spencer Collins leads it at an estimated $19.8 million, and six officers combine for about $62.4 million ¹.

Chief financial officer Jason Child's two most recent sales, 10,400 shares at $255.33 on August 27 and 10,400 at $300 on September 21, each state they ran under a Rule 10b5-1 plan↗, a schedule of automatic sales set months in advance, adopted on May 22 ^{6 7}. The September 21 sale landed the day the stock jumped almost 15% ³. Chief commercial officer William Abbey's June 1 sales, 2,644 shares at $383.73 and 3,922 at $415.52 near the stock's top, carry no plan footnote ⁸.

Chief accounting officer Laura Bartels's August 17 entry is marked code F, shares withheld to cover tax when units vested, which the form reports as a sale ⁹. A Form 4 lists the sale; it says nothing about why.

The institutions stood at June 30; the officers sold up to the trial

Second-quarter 13F filings, the quarterly snapshots of holdings that institutions file with the Securities and Exchange Commission, show 542 holders adding ARM shares and 357 trimming them ¹. Invesco▲+1.59% — Invesco, up 1.59 percent today added 9.86 million shares, about $3.5 billion, while Morgan Stanley▲+0.87% — Morgan Stanley, up 0.87 percent today halved its stake ¹.

Those positions were fixed on June 30, before the trial opened on October 5 ³ and the verdict eight days later ². The latest dated officer sale, Child's on September 21, came two weeks before the trial opened ⁷. The median of 15 recent analyst targets is $300, against the $255 close on October 13 ^{1 3}.

What November 4 decides

Arm reports fiscal Q2 on November 4, guiding to $1.38 billion in revenue plus or minus $50 million, with royalty growth, by Child's estimate, closer to the high teens than the roughly 20% Arm had expected ³. Noreika's ruling on the five-year clause remains open ^{2 3}.

The board has priced its own ambition. Shareholders approved on September 9 a 425,000-unit award for Haas that pays 25 percent if Arm's market value reaches $1 trillion by March 2029, 25 percent more at $1.5 trillion by 2030, and the remaining half only at $2 trillion by March 2031 ^{10 11}.